ClinicalTrials.Veeva

Menu
A

Angels Clinical Research Institute | Tampa, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

KarXT
AR1001
Obeldesivir

Parent organization

This site is a part of Angels Clinical Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with mod...

Enrolling
Alzheimer Disease
Drug: Placebo
Drug: KarXT

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027, CN012...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT
Drug: KarX-EC

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Trial sponsors

Gilead Sciences logo
Karuna Therapeutics logo
A
BioNTech logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems